MALAT1 promotes the proliferation and invasion of thyroid cancer cells via regulating the expression of IQGAP1

Biomedicine and Pharmacotherapy

Volumn 83, Issue , 2016, Pages 1-7

  Huang, Jian kang ^a   Ma, Ling ^a   Song, Wen hua ^a   Lu, Bang yu ^b   Huang, Yu bin ^b   Dong, Hui ming ^a   Ma, Xiao kai ^a   Zhu, Zheng zhi ^a   Zhou, Rui ^a  

^a BENGBU MEDICAL COLLEGE   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Invasion; IQGAP1; MALAT1; Proliferation; Thyroid cancer

Indexed keywords

IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; PROTEIN; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LONG UNTRANSLATED RNA; MALAT1 LONG NON-CODING RNA, HUMAN;

ANIMAL CELL; ARTICLE; ASSAY; CANCER CELL; CANCER GROWTH; CANCER TISSUE; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THYROID CANCER; TRANSWELL ASSAY; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SUBCUTANEOUS TISSUE; THYROID TUMOR; TUMOR CELL LINE; TUMOR INVASION;

CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; RAS GTPASE-ACTIVATING PROTEINS; RNA, LONG NONCODING; SUBCUTANEOUS TISSUE; THYROID NEOPLASMS; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84974781479     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.05.039     Document Type: Article

References (28)

1. Pellegriti G., Frasca F., Regalbuto C., Squatrito S., Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J. Cancer Epidemiol. 2013, 2013. 965212-965212.
2. Carneiro R.M., Carneiro B.A., Agulnik M., Kopp P.A., Giles F.J. Targeted therapies in advanced differentiated thyroid cancer. Cancer Treatment Rev. 2015, 41.
3. Wong A.S.T., Gumbiner B.M. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J. Cell Biol. 2003, 161(6):1191-1203.
4. Noritake J., Watanabe T., Sato K., Wang S., Kaibuchi K. IQGAP1: a key regulator of adhesion and migration. J. Cell Sci. 2005, 118(10):2085-2092.
5. Ho Y.-D., Joyal J.L., Li Z., Sacks D.B. IQGAP1 integrates Ca2+/calmodulin and Cdc42 signaling. J. Biol. Chem. 1999, 274(1):464-470.
6. Hart M.J., Callow M.G., Souza B., Polakis P. IQGAP1: a calmodulin-binding protein with a rasGAP-related domain, is a potential effector for cdc42Hs. EMBO J. 1996, 15(12):2997-3005.
7. Mateer S.C., McDaniel A.E., Nicolas V., Habermacher G.M., Lin M.-J.S., Cromer D.A., King M.E., Bloom G.S. The mechanism for regulation of the F-actin binding activity of IQGAP1 by calcium/calmodulin. J. Biol. Chem. 2002, 277(14):12324-12333.
8. Masaki F., Takashi W., Jun N., Masato N., Masaki Y., Shinya K., Yoshiharu M., Akihiro I., Franck P., Kozo K. Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170. Cell 2002, 109(7):873-885.
9. Zhi L., Dingxie L., Ermal B., El-Naggar A.K., Vasily V., Mingzhao X. IQGAP1 plays an important role in the invasiveness of thyroid cancer. Clin. Cancer Res. 2010, 16(24):6009-6018.
10. Guru S.C., Agarwal S.K., Manickam P., Olufemi S.E., Crabtree J.S., Weisemann J.M., Kester M.B., Kim Y.S., Wang Y., Emmert-Buck M.R. A transcript map for the 2.8-Mb region containing the multiple endocrine neoplasia type 1 locus. Genome Res. 1997, 7(7):725-735.
11. Ji P., Diederichs S., Wang W., Böing S., Metzger R., Schneider P.M., Tidow N., Brandt B., Buerger H., Bulk E. MALAT-1: a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22(39):8031-8041.
12. Lin R., Maeda S., Liu C., Karin M., Edgington T.S. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26(6):851-858.
13. Hutchinson J.N., Ensminger A.W., Clemson C.M., Lynch C.R., Lawrence J.B., Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genom. 2007, 8(1).
14. Yang M.-H., Hu Z.-Y., Xu C., Xie L.-Y., Wang X.-Y., Chen S.-Y., Li Z.-G. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 2015, 1852(1):166-174.
15. Liu D., Liu Z., Condouris S., Xing M. BRAF V600E maintains proliferation: transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells. J. Clin. Endocrinol. Metab. 2007, 92(6):2264-2271.
16. Acunzo M., Visone R., Romano G., Veronese A., Lovat F., Palmieri D., Bottoni A., Garofalo M., Gasparini P., Condorelli G. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 2012, 31(5):634-642.
17. Yoon H., He H., Nagy R., Davuluri R., Suster S., Schoenberg D., Pellegata N., Chapelle Ade L. Identification of a novel noncoding RNA gene: NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest. Int. J. Cancer 2007, 121(4):767-775.
18. Zhou Q., Chen J., Feng J., Wang J. Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR). Tumor Biol. 2016, 2015:1-9.
19. Wang C., Yan G., Zhang Y., Jia X., Bo P. Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1. Neoplasma 2015.
20. Wu Y., Lu W., Xu J., Shi Y., Zhang H., Xia D. Prognostic value of long non-coding RNA MALAT1 in cancer patients. Tumor Biol. 2015.
21. Tony G., Monika H.M., Moritz E., Jeff H., Youngsoo K., Gene H., Alexey R., Gayatri A., Marion S., Matthias G. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013, 73(3):1180-1189.
22. Cho S.F., Chang Y.C., Chang C.S., Lin S.F., Liu Y.C., Hsiao H.H., Chang J.G., Liu T.C. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer 2014, 14(1). 809-809.
23. Fengjie G., Yalin L., Yan L., Jiajia W., Yuehui L., Guancheng L. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim. Biophys. Sin. 2010, 42(3):224-229.
24. Lai M.C., Yang Z., Zhou L., Zhu Q.Q., Xie H.Y., Zhang F., Wu L.M., Chen L.M., Zheng S.S. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med. Oncol. 2012, 29(3):1810-1816.
25. Kuroda S., Fukata M., Nakagawa M., Fujii K., Nakamura T., Ookubo T., Izawa I., Nagase T., Nomura N., Tani H. Role of IQGAP1, a target of the small GTPases cdc42 and rac1, in regulation of E-Cadherin-Mediated cell-Cell adhesion. Science 1998, 281(5378):832-835.
26. Yamaoka-Tojo M., Ushio-Fukai M., Hilenski L., Dikalov S.I., Chen Y.E., Tojo T., Fukai T., Fujimoto M., Patrushev N.A., Wang N. IQGAP1: a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species-dependent endothelial migration and proliferation. Circ. Res. 2004, 95(3):276-283.
27. Hayashi H., Nabeshima K., Aoki M., Hamasaki M., Enatsu S., Yamauchi Y., Yamashita Y., Iwasaki H. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion. Int. J. Cancer 2010, 126(11):2563-2574.
28. Mataraza J.M., Briggs M.W., Zhigang L., Alan E., Ridley A.J., Sacks D.B. IQGAP1 promotes cell motility and invasion. J. Biol. Chem. 2003, 278(42):41237-41245.